168 related articles for article (PubMed ID: 21936827)
1. War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection.
Drannik AG; Henrick BM; Rosenthal KL
Biochem Soc Trans; 2011 Oct; 39(5):1427-32. PubMed ID: 21936827
[TBL] [Abstract][Full Text] [Related]
2. WAP domain proteins as modulators of mucosal immunity.
Wilkinson TS; Roghanian A; Simpson AJ; Sallenave JM
Biochem Soc Trans; 2011 Oct; 39(5):1409-15. PubMed ID: 21936824
[TBL] [Abstract][Full Text] [Related]
3. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
[TBL] [Abstract][Full Text] [Related]
5. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition.
Iqbal SM; Ball TB; Levinson P; Maranan L; Jaoko W; Wachihi C; Pak BJ; Podust VN; Broliden K; Hirbod T; Kaul R; Plummer FA
AIDS; 2009 Aug; 23(13):1669-77. PubMed ID: 19553806
[TBL] [Abstract][Full Text] [Related]
6. Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.
Sallenave JM
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):635-43. PubMed ID: 20395631
[TBL] [Abstract][Full Text] [Related]
7. SLPI and elafin: one glove, many fingers.
Williams SE; Brown TI; Roghanian A; Sallenave JM
Clin Sci (Lond); 2006 Jan; 110(1):21-35. PubMed ID: 16336202
[TBL] [Abstract][Full Text] [Related]
8. Novel innate immune functions of the whey acidic protein family.
Bingle CD; Vyakarnam A
Trends Immunol; 2008 Sep; 29(9):444-53. PubMed ID: 18676177
[TBL] [Abstract][Full Text] [Related]
9. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
[TBL] [Abstract][Full Text] [Related]
10. SLPI and elafin: multifunctional antiproteases of the WFDC family.
Scott A; Weldon S; Taggart CC
Biochem Soc Trans; 2011 Oct; 39(5):1437-40. PubMed ID: 21936829
[TBL] [Abstract][Full Text] [Related]
11. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
Firoz Mian M; Ashkar AA
Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
[TBL] [Abstract][Full Text] [Related]
12. Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.
Ghosh M; Shen Z; Fahey JV; Cu-Uvin S; Mayer K; Wira CR
Immunology; 2010 Feb; 129(2):207-19. PubMed ID: 19824918
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
Hirbod T; Broliden K
J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
[TBL] [Abstract][Full Text] [Related]
14. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
Baranger K; Zani ML; Labas V; Dallet-Choisy S; Moreau T
PLoS One; 2011; 6(6):e20976. PubMed ID: 21687692
[TBL] [Abstract][Full Text] [Related]
15. The WAP protein Trappin-2/Elafin: a handyman in the regulation of inflammatory and immune responses.
Verrier T; Solhonne B; Sallenave JM; Garcia-Verdugo I
Int J Biochem Cell Biol; 2012 Aug; 44(8):1377-80. PubMed ID: 22634606
[TBL] [Abstract][Full Text] [Related]
16. In silico study of whey-acidic-protein domain containing oral protease inhibitors.
Idoji Y; Watanabe Y; Yamashita A; Yamanishi K; Nishiguchi S; Shimada K; Yasunaga T; Yamanishi H
Int J Mol Med; 2008 Apr; 21(4):461-8. PubMed ID: 18360692
[TBL] [Abstract][Full Text] [Related]
17. Human neutrophil elastase inhibitors in innate and adaptive immunity.
Fitch PM; Roghanian A; Howie SE; Sallenave JM
Biochem Soc Trans; 2006 Apr; 34(Pt 2):279-82. PubMed ID: 16545094
[TBL] [Abstract][Full Text] [Related]
18. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
19. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
20. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
